DEA schedule
Is hydromorphone a controlled substance?
Federal schedule for hydromorphone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Hydromorphone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Hydromorphone (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted hydromorphone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 71 prescription listings from 17 labelers, all Schedule II |
| DEA controlled substances list | Hydromorphone: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Hydromorphone | 9150 | II | Yes | Dilaudid; dihydromorphinone | Listed by name |
Hydromorphone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 76045-121 | Dilaudid | injection, solution | .2 mg/mL | Fresenius Kabi USA, LLC | CII |
| 76045-009 | Dilaudid | injection, solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 76045-010 | Dilaudid | injection, solution | 2 mg/mL | Fresenius Kabi USA, LLC | CII |
| 42858-416 | Dilaudid | solution | 5 mg/5mL | Rhodes Pharmaceuticals LLC | CII |
| 42858-122 | Dilaudid | tablet | 2 mg/1 | Rhodes Pharmaceuticals LLC | CII |
| 42858-234 | Dilaudid | tablet | 4 mg/1 | Rhodes Pharmaceuticals LLC | CII |
| 42858-338 | Dilaudid | tablet | 8 mg/1 | Rhodes Pharmaceuticals LLC | CII |
| 0409-1805 | Hydromorphone Hydrochloride | injection, solution | .25 mg/.5mL | Hospira, Inc. | CII |
| 0409-4264 | Hydromorphone Hydrochloride | injection, solution | .5 mg/.5mL | Hospira, Inc. | CII |
| 0409-1283 | Hydromorphone Hydrochloride | injection, solution | 1 mg/mL | Hospira, Inc. | CII |
| 0409-1283 | Hydromorphone Hydrochloride | injection, solution | 1 mg/mL | Hospira, Inc. | CII |
| 63323-852 | Hydromorphone Hydrochloride | injection, solution | 1 mg/mL | Fresenius Kabi USA, LLC | CII |
| 63323-851 | Hydromorphone Hydrochloride | injection, solution | 10 mg/mL | Fresenius Kabi USA, LLC | CII |
| 0409-1312 | Hydromorphone Hydrochloride | injection, solution | 2 mg/mL | Hospira, Inc. | CII |
| 0409-1312 | Hydromorphone Hydrochloride | injection, solution | 2 mg/mL | Hospira, Inc. | CII |
| 0409-3365 | Hydromorphone Hydrochloride | injection, solution | 2 mg/mL | Hospira, Inc. | CII |
| 0641-6254 | Hydromorphone Hydrochloride | injection, solution | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 63323-853 | Hydromorphone Hydrochloride | injection, solution | 2 mg/mL | Fresenius Kabi USA, LLC | CII |
| 0409-1304 | Hydromorphone Hydrochloride | injection, solution | 4 mg/mL | Hospira, Inc. | CII |
| 63323-854 | Hydromorphone Hydrochloride | injection, solution | 4 mg/mL | Fresenius Kabi USA, LLC | CII |
| 0641-6259 | Hydromorphone Hydrochloride | injection | .2 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0641-6206 | Hydromorphone Hydrochloride | injection | .5 mg/.5mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0641-6169 | Hydromorphone Hydrochloride | injection | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0641-6151 | Hydromorphone Hydrochloride | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0641-6170 | Hydromorphone Hydrochloride | injection | 2 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 0409-2634 | Hydromorphone Hydrochloride | injection, solution | 10 mg/mL | Hospira, Inc. | CII |
| 0703-0018 | Hydromorphone Hydrochloride | injection, solution | 10 mg/mL | Teva Parenteral Medicines, Inc. | CII |
| 0703-0110 | Hydromorphone Hydrochloride | injection, solution | 10 mg/mL | Teva Parenteral Medicines, Inc. | CII |
| 0703-0113 | Hydromorphone Hydrochloride | injection, solution | 10 mg/mL | Teva Parenteral Medicines, Inc. | CII |
| 0054-0386 | Hydromorphone Hydrochloride | solution | 1 mg/mL | Hikma Pharmaceuticals USA Inc. | CII |
| 42858-304 | Hydromorphone Hydrochloride | solution | 5 mg/5mL | Rhodes Pharmaceuticals LLC | CII |
| 43602-001 | Hydromorphone Hydrochloride | solution | 5 mg/5mL | Ascent Pharmaceuticals Inc | CII |
| 60687-566 | Hydromorphone Hydrochloride | solution | 5 mg/5mL | American Health Packaging | CII |
| 0406-3243 | Hydromorphone Hydrochloride | tablet | 2 mg/1 | SpecGx LLC | CII |
| 13107-107 | HYDROMORPHONE HYDROCHLORIDE | tablet | 2 mg/1 | Aurolife Pharma, LLC | CII |
| 42858-301 | Hydromorphone Hydrochloride | tablet | 2 mg/1 | Rhodes Pharmaceuticals LLC | CII |
| 43602-002 | HYDROMORPHONE HYDROCHLORIDE | tablet | 2 mg/1 | Ascent Pharmaceuticals Inc | CII |
| 60687-579 | Hydromorphone Hydrochloride | tablet | 2 mg/1 | American Health Packaging | CII |
| 63629-4284 | Hydromorphone Hydrochloride | tablet | 2 mg/1 | Bryant Ranch Prepack | CII |
| 67296-1414 | Hydromorphone Hydrochloride | tablet | 2 mg/1 | Redpharm Drug | CII |
Showing 40 of 71 listings.
Questions
Is hydromorphone a controlled substance?
Yes. Hydromorphone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Hydromorphone (Schedule II).
Is hydromorphone a narcotic?
Yes. The DEA list marks hydromorphone as a narcotic (NARC = Y) and places it in Schedule II. Its FDA established pharmacologic class is Opioid Agonist.
What schedule is hydromorphone?
Hydromorphone is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Hydromorphone
- What is Hydromorphone used for?FDA label uses
- Generic for DilaudidFDA Orange Book
- Generic for Dilaudid-hpFDA Orange Book
- Generic for ExalgoFDA Orange Book
- What is Dilaudid used for?FDA label uses
- Is Dilaudid a controlled substance?Schedule II
- Opioid Agonists listFDA drug class
- NDC 0409-1283Hydromorphone NDC record
- NDC 0409-1304Hydromorphone NDC record
- Schedule II drugs listDEA schedule